CAMBRIDGE, Mass., May 1, 2024 /Business Wire/ — Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform ...
CAMBRIDGE, Mass., April 22, 2024 /Business Wire/ — Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform ...
CAMBRIDGE, Mass., April 3, 2024/Business Wire/ — Vesigen Therapeutics, Inc., a biotechnology company developing a novel non-viral delivery platform for ...
Vesigen proposal selected as a “Winning Solution” for programmable delivery systems for gene editing Proposal builds on recent data demonstrating ...
First demonstration of directed tropism of ARMMs for cell type-specific delivery of therapeutic payloads Dose-dependent gene editing observed across multiple ...
Robust uptake observed in photoreceptors and retinal pigment epithelium (RPE) of mice, minipigs, and non-human primates Additional data demonstrate rescue ...